Detalhe da pesquisa
1.
Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia.
BMC Genet
; 17 Suppl 1: 14, 2016 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26822197
2.
The ability of multipotent mesenchymal stromal cells from the bone marrow of patients with leukemia to maintain normal hematopoietic progenitor cells.
Eur J Haematol
; 97(3): 245-52, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26643284
3.
The impact of dasatinib on pregnancy outcomes.
Am J Hematol
; 90(12): 1111-5, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26348106
4.
Risks and challenges of CML management during pregnancy: Looking for a balanced decision.
Eur J Haematol
; 102(4): 378-379, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30672625
5.
Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry.
Leukemia
; 38(4): 788-795, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38388649
6.
Clinical Outcomes in Patients With COVID-19 and Hematologic Disease.
Clin Lymphoma Myeloma Leuk
; 23(8): 589-598, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37236904
7.
Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations.
Ther Adv Hematol
; 11: 2040620720966120, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33194164
8.
Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI.
Clin Lymphoma Myeloma Leuk
; 20(5): 267-271, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32146103
9.
Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients.
BMC Med Genomics
; 12(Suppl 2): 37, 2019 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871622
10.
Breastfeeding in Patients with Chronic Myeloid Leukaemia: Case Series with Measurements of Drug Concentrations in Maternal Milk and Literature Review.
Mediterr J Hematol Infect Dis
; 10(1): e2018027, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29755704
11.
Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment.
Leuk Lymphoma
; 59(3): 733-738, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28703026
12.
Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia.
PLoS One
; 12(9): e0182901, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28902850
13.
Whole-exome sequencing reveals potential molecular predictors of relapse after discontinuation of the targeted therapy in chronic myeloid leukemia patients.
Leuk Lymphoma
; 57(7): 1669-76, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26759060
14.
Genetic markers of stable molecular remission in chronic myeloid leukemia after targeted therapy discontinuation.
Leuk Lymphoma
; 59(10): 2512-2515, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29424604